VIRCA NICHOLAS J 4
4 · Inhibitor Therapeutics, Inc. · Filed Sep 21, 2020
Insider Transaction Report
Form 4
VIRCA NICHOLAS J
DirectorPresident and CEO
Transactions
- Award
Common Stock Option
2020-09-17+100,000→ 100,000 totalExercise: $0.05From: 2020-09-17Exp: 2030-09-17→ Common Stock (100,000 underlying)